GE Global Research And Eli Lilly and Company Achieve Significant Advancement in Cancer Research

NEW YORK & INDIANAPOLIS--(BUSINESS WIRE)--Scientists at GE Global Research (NYSE: GE), and researchers at Eli Lilly and Company (NYSE: LLY) today announced a significant advancement in cancer research resulting from the two companies’ collaboration formed in October 2007.

MORE ON THIS TOPIC